Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cattle Diseases D002418 24 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Testicular Diseases D013733 15 associated lipids
Lymphoma, Large B-Cell, Diffuse D016403 13 associated lipids
Melanoma D008545 69 associated lipids
Weight Gain D015430 101 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Proteinuria D011507 30 associated lipids
Genital Neoplasms, Male D005834 3 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Protein Deficiency D011488 5 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Leiomyoma D007889 8 associated lipids
Nutrition Disorders D009748 6 associated lipids
Swine Diseases D013553 16 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Infertility, Female D007247 5 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Acute Lung Injury D055371 33 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Darier Disease D007644 2 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Trypanosomiasis, African D014353 5 associated lipids
Retinoblastoma D012175 12 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Carcinoma, Mucoepidermoid D018277 3 associated lipids
Lung Injury D055370 14 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Prostatic Neoplasms, Castration-Resistant D064129 3 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
de Buckle TS et al. Two food applications of cottonseed flours and meals. 1979 J Am Oil Chem Soc pmid:583421
Pandey SN and Thejappa N Study on relationship between oil, protein, and gossypol in cottonseed kernels. 1975 J Am Oil Chem Soc pmid:1242138
Smith FH and Clawson AJ The effects of dietary gossypol on animals. 1970 J Am Oil Chem Soc pmid:5487114
Smith FH Determination of gossypol in leaves and flower buds of Gossypium. 1967 J Am Oil Chem Soc pmid:6041387
Muzaffaruddin M and Saxena ER Physicochemical studies on the composition and stability of metal-gossypol complexes. I. Fe+++ gossypol complex. 1966 J Am Oil Chem Soc pmid:5939582
Skutches CL and Smith FH Metabolism of gossypol, biosynthesized from methyl-14C-and carboxyl-14 C-labeled sodium acetate, in rat. 1974 J Am Oil Chem Soc pmid:4479245
CASADY RB et al. FURTHER STUDIES OF DEGOSSYPOLIZED COTTONSEED MEAL AS A SOURCE OF PLANT PROTEIN IN RABBIT FEEDS. 1965 J Am Oil Chem Soc pmid:14328364
Woolley RJ Contraception--a look forward, Part II: Mifepristone and gossypol. 1991 Mar-Apr J Am Board Fam Pract pmid:1823560
Zakhidov ST et al. [The modifying cytogenetic effects of gossypol and its derivatives]. 1994 Jul-Aug Izv. Akad. Nauk. Ser. Biol. pmid:7987209
Zakhidov ST et al. [Clastogenic action of gossypol on spermatogenic cells in rats studied by counting micronuclei]. 1988 May-Jun Izv Akad Nauk SSSR Biol pmid:3411013
Morris ID Gossypol: a male contraceptive with potential? 1986 IRCS J Med Sci pmid:12280996
Liang XS et al. Developing gossypol derivatives with enhanced antitumor activity. 1995 Invest New Drugs pmid:8729944
Schelman WR et al. A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer. 2014 Invest New Drugs pmid:23860642
Final report on the safety assessment of Hydrogenated Cottonseed Oil, Cottonseed (Gossypium) Oil, Cottonseed Acid, Cottonseed Glyceride, and Hydrogenated Cottonseed Glyceride. 2001 Int. J. Toxicol. pmid:11558638
Strøm-Hansen T et al. Interaction of gossypol with amino acids and peptides as a model of enzyme inhibition. 1989 Int. J. Pept. Protein Res. pmid:2599770
Maliwal BP et al. Spectroscopic study of the interaction of gossypol with bovine serum albumin. 1985 Int. J. Pept. Protein Res. pmid:4019021
Zhang Y et al. The (-)-enantiomer of gossypol inhibits proliferation of stromal cells derived from human breast adipose tissues by enhancing transforming growth factor beta1 production. 1998 Int. J. Oncol. pmid:9824647
Sadahira K et al. Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway. 2014 Int. J. Oncol. pmid:25231749
Jiang J et al. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling. 2009 Int. J. Mol. Med. pmid:19513537
Ye W et al. Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells. 2010 Int. J. Mol. Med. pmid:20514430
Chang CC et al. Studies on gossypol. I. Toxicity, antifertility, and endocrine analyses in male rats. 1982 Int. J. Fertil. pmid:6131039
Ke YB and Tso WW Variations of gossypol susceptibility in rat spermatozoa during spermatogenesis. 1982 Int. J. Fertil. pmid:6122656
Ko CH et al. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells. 2007 Int. J. Cancer pmid:17597109
Ionov M et al. Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone. 2012 Int. J. Biol. Macromol. pmid:22910577
Cuéllar A and Ramírez J Further studies on the mechanism of action of gossypol on mitochondrial membrane. 1993 Int. J. Biochem. pmid:8405656
Grankvist K Gossypol-induced free radical toxicity to isolated islet cells. 1989 Int. J. Biochem. pmid:2684701
Prasad MR and Diczfalusy E New contraceptives for men. What are the prospects? 1983 Int. J. Androl. pmid:6413430
Tso WW and Lee CS Lactate dehydrogenase-X: an isozyme particularly sensitive to gossypol inhibition. 1982 Int. J. Androl. pmid:7107034
Tso WW and Lee CS Potassium leakage: not the cause of gossypol induced anti-motility in spermatozoa. 1982 Int. J. Androl. pmid:7118270
Kaur S Effect of gossypol on the concentration of sodium and potassium in the rat epididymis. 1989 Int. J. Androl. pmid:2807585
Coulson PB et al. Short term metabolic effects of the anti-fertility agent, gossypol, on various reproductive organs of male mice. 1980 Int. J. Androl. pmid:7440012
Michael AE 11 beta HSD and the mechanism of gossypol-induced hypokalemia. 1998 Int. J. Androl. pmid:9805249
Vongsorasak L and Svasti J Inhibition of liquefaction and protein degradation in human semen by gossypol. 1985 Int. J. Androl. pmid:3835162
Meng GD et al. Recovery of sperm production following the cessation of gossypol treatment: a two-centre study in China. 1988 Int. J. Androl. pmid:3356480
Akingbemi BT et al. Infection with Trypanosoma brucei potentiates the antifertility effect of gossypol, especially in the protein-malnourished male rat. 1996 Int. J. Androl. pmid:8876268
Kalla NR et al. alpha-Glucosidase activity in the rat epididymis under different physiological conditions. 1997 Int. J. Androl. pmid:9292319
Lindberg MC et al. Comparative anti-fertility effects of gossypol enantiomers in male hamsters. 1987 Int. J. Androl. pmid:3654015
Steiner M et al. In vivo study of LDH isoenzyme activities in heart, liver and testis cytosols of gossypol-treated rats. 1984 Int. J. Androl. pmid:6526516
Kainz V et al. The effect of gossypol acetic acid on the different stages of the spermatogenic cycle in the rat. 1988 Int. J. Androl. pmid:3215704
Yu ZH and Chan HC Gossypol as a male antifertility agent--why studies should have been continued. 1998 Int. J. Androl. pmid:9639145
Waites GM et al. Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. 1998 Int. J. Androl. pmid:9639146
Breitbart H et al. Effect of gossypol-acetic acid on calcium transport and ATPase activity in plasma membranes from ram and bull spermatozoa. 1984 Int. J. Androl. pmid:6151940
Qian SZ Gossypol-hypokalaemia interrelationships. 1985 Int. J. Androl. pmid:3908325
Zhang GY et al. Dynamic study of serum gonadotrophin and testosterone levels in gossypol-treated men. Long term follow-up study of 60 cases. 1985 Int. J. Androl. pmid:3932223
Gu ZP et al. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol. 1990 Int. J. Androl. pmid:2117586
Tang F and Wong PY Serum potassium and aldosterone levels in gossypol-treated rats. 1984 Int. J. Androl. pmid:6724725
Eliasson R and Virji N Effects of gossypol acetic acid on the activity of LDH-C4 from human and rabbit spermatozoa. 1983 Int. J. Androl. pmid:6840877
Aitken RJ et al. An analysis of the direct effects of gossypol on human spermatozoa. 1983 Int. J. Androl. pmid:6862672
Johnsen O et al. Gossypol; a potent inhibitor of human sperm acrosomal proteinase. 1982 Int. J. Androl. pmid:6761275
Huo M et al. Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models. 2013 Int. Immunopharmacol. pmid:23352443